Annovis Bio SG&A Expense (TTM) Trends

Annovis Bio Inc (ANVS)

15.31 +4.21 (+37.93%) USD | NYSE | Jul 08, 16:00

15.15 -0.16 (-1.05%) After-Hours: 19:38

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	5.356M
December 31, 2023	6.244M
September 30, 2023	6.299M
June 30, 2023	7.634M
March 31, 2023	8.075M
December 31, 2022	8.996M
September 30, 2022	10.44M
June 30, 2022	9.551M
March 31, 2022	8.323M
December 31, 2021	6.058M
September 30, 2021	3.520M

Date	Value
June 30, 2021	2.932M
March 31, 2021	3.909M
December 31, 2020	3.586M
September 30, 2020	3.198M
June 30, 2020	2.552M
March 31, 2020	1.165M
December 31, 2019	0.8294M
September 30, 2019	0.8754M
June 30, 2019	0.76M
March 31, 2019	0.6509M
December 31, 2018	0.6023M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

0.8294M

Minimum

Dec 2019

10.44M

Maximum

Sep 2022

5.239M

Average

5.356M

Median

Mar 2024

SG&A Expense (TTM) Benchmarks